Skip to main content
logo
Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
13.95
+0.73 (5.52%)
Aug 19, 2026, 4:00 PM EDT - Market closed

Korro Bio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2.386.392.27---
Revenue Growth
-62.08%181.46%----
Gross Profit
-41.02-48.74-50.04-48--
Operating Income
-76.9-87.34-91.91-84.53-59-35.49
Net Income
-106.64-117.26-83.58-81.17-58.03-21.96
Earnings Per Share
-8.88-12.48-9.37-53.08-227.42-4.94
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
137.9285.19163.05166.1555.25118.53
Total Debt
42.2143.4944.7733.213.13-
Net Cash (Debt)
95.7141.7118.29132.9452.12118.53
Net Cash Growth
27.62%-64.75%-11.02%155.08%-56.03%-
Net Cash Per Share
7.974.4413.2686.93204.2426.65

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-67.95-78.56-60.07-67.28-53.65-32.09
Capital Expenditures
-0.32-0.52-17.9-7.84-5.21-4.45
Free Cash Flow
-68.27-79.08-77.98-75.12-58.86-36.54
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Margin
-3228.34%-1366.43%-4047.12%---
Pretax Margin
-4441.86%-1824.52%-3674.15%---
Profit Margin
-4477.08%-1834.48%-3680.36%---
FCF Margin
-2865.87%-1237.16%-3433.55%---

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
86.2411.80157.04---